Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Why biotech is becoming attractive to investors again

The “biotech winter” is over. Momentum is returning to the sector. In the finews podcast, Christian Koch, Head of the BB Biotech Team, explains why expiring blockbuster patents, renewed M&A activity and technological advances could position the biopharmaceutical industry for a potential new upswing – and what this means for investors.
13.03.2026 - Christian Koch
ENGLISH: Why Biotech is Becoming Exciting for Investors Again

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 0.33%Active share: 68.90Anzahl Positionen: 26
    Launch date: 16. November 1993